Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXPHealthcare / Drug Manufacturers - Major / USA
0.5700-0.0200-3.39%Vol 644 2331Y Perf -98.61%
Jul 22nd, 2019 15:59
BID0.5700 ASK0.5800
Open0.5800 Previous Close0.5900
Pre-Market0.59 After-Trading0.58
 - -%  0.01 1.75%
Target Price
6.67 
Analyst Rating
Strong Buy 1.00
Potencial %
1 070.18 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)4 
Earnings Rating
Sell
Price Range Ratio 52wk %
0.00 
Earnings Date
12th Aug 2019

Today's Price Range

0.57000.5900

52wk Range

0.570042.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.00%
1 Month
-59.86%
3 Months
-75.32%
6 Months
-70.00%
1 Year
-98.61%
3 Years
-99.72%
5 Years
-99.95%
10 Years
-

Name / TickerPriceChg.Chg.%
TNXP0.5700-0.0200-3.39
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q01 2019-1.28-1.29-0.78
Q04 2018-3.87-6.10-57.62
Q03 2018-6.50-5.7012.31
Q02 2018-7.60-7.303.95
Q01 2018-7.00-8.80-25.71
Q04 2017-7.70-6.7012.99
Q03 2017-6.80-7.00-2.94
Q02 2017-0.73-0.6510.96
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.99-2.06Negative
9/2019 QR-0.96-5.49Negative
12/2019 FY-4.05-1.50Negative
12/2020 FY-2.69-35.18Negative
Next Report Date12th Aug 2019
Estimated EPS Next Report-0.99
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume644 233
Shares Outstanding (in ths.)6 338
Trades Count624
Dollar Volume365 883
Avg. Volume977 091
Avg. Weekly Volume1 604 982
Avg. Monthly Volume687 165
Avg. Quarterly Volume491 587
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
3 (100.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.50

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.

CEO: Seth Lederman

Teplephone: +1 212 980-9155

Address: 509 Madison Avenue, New York 10022, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

54%46%

Bearish Bullish

57%43%

Bearish Bullish

55%45%

News